SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of 10x Genomics, Inc. (NASDAQ: TXG) and Encourages Investors to Contact the Firm

PHILADELPHIA, PA / ACCESSWIRE / June 11, 2024 / Kaskela Law LLC announces that it is investigating 10x Genomics, Inc. (NASDAQ:TXG) on behalf of the company’s shareholders.

The purpose of the investigation is to determine whether 10x Genomics and/or the Company’s officers and directors violated the securities laws or breached their fiduciary duty to the Company’s investors in connection with recent corporate actions.

For further information regarding this investigation and their legal rights and options, 10x Genomics shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229-0750 or (888) 715-1740 or click on the following link (or copy and paste the link into your browser if necessary):

https://kaskelalaw.com/cases/10x-genomics/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance and merger and acquisition litigation on a contingency basis. For more information about Kaskela Law LLC, visit www.kaskelalaw.com.

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

This notice may be considered attorney advertising in certain jurisdictions.

SOURCE: Kaskela Lawyers

View the original press release on accesswire.com.